Chunlong Xu

1.8k total citations · 2 hit papers
25 papers, 787 citations indexed

About

Chunlong Xu is a scholar working on Molecular Biology, Genetics and Plant Science. According to data from OpenAlex, Chunlong Xu has authored 25 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 8 papers in Genetics and 3 papers in Plant Science. Recurrent topics in Chunlong Xu's work include CRISPR and Genetic Engineering (19 papers), Virus-based gene therapy research (6 papers) and RNA regulation and disease (5 papers). Chunlong Xu is often cited by papers focused on CRISPR and Genetic Engineering (19 papers), Virus-based gene therapy research (6 papers) and RNA regulation and disease (5 papers). Chunlong Xu collaborates with scholars based in China, United States and Slovenia. Chunlong Xu's co-authors include Qingquan Xiao, Hui Yang, Yuanhua Liu, Hui Yang, Yingsi Zhou, Bingbing He, Zikang Wang, Jinsheng Lai, Xiaona Huo and Xue Dong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Chunlong Xu

24 papers receiving 765 citations

Hit Papers

Programmable RNA editing with compact CRISPR–Cas13 system... 2021 2026 2022 2024 2021 2023 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunlong Xu China 14 725 160 62 55 54 25 787
Ryan J. Cecchi United States 5 770 1.1× 143 0.9× 56 0.9× 24 0.4× 38 0.7× 7 865
Ramu Gopalappa South Korea 7 951 1.3× 335 2.1× 41 0.7× 31 0.6× 89 1.6× 9 1.0k
Nicola A. Kearns United States 7 798 1.1× 135 0.8× 58 0.9× 20 0.4× 69 1.3× 10 858
Changyang Zhou China 11 665 0.9× 184 1.1× 47 0.8× 34 0.6× 59 1.1× 16 707
Joy E. Horng United States 7 789 1.1× 147 0.9× 95 1.5× 25 0.5× 81 1.5× 12 851
Charles D. Yeh United States 8 641 0.9× 183 1.1× 67 1.1× 28 0.5× 96 1.8× 9 703
Yuchen Gao United States 9 913 1.3× 141 0.9× 82 1.3× 16 0.3× 65 1.2× 10 1000
Yayoi Kunihiro Japan 7 541 0.7× 225 1.4× 50 0.8× 18 0.3× 55 1.0× 8 619
Gokul N. Ramadoss United States 5 481 0.7× 90 0.6× 38 0.6× 40 0.7× 21 0.4× 6 644

Countries citing papers authored by Chunlong Xu

Since Specialization
Citations

This map shows the geographic impact of Chunlong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunlong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunlong Xu more than expected).

Fields of papers citing papers by Chunlong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunlong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunlong Xu. The network helps show where Chunlong Xu may publish in the future.

Co-authorship network of co-authors of Chunlong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunlong Xu. A scholar is included among the top collaborators of Chunlong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunlong Xu. Chunlong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Tao, Xinxin Ke, Yingying Yu, et al.. (2025). NAPTUNE: nucleic acids and protein biomarkers testing via ultra-sensitive nucleases escalation. Nature Communications. 16(1). 1331–1331. 9 indexed citations
2.
Wei, Yinghui, Ming Jin, Shuhong Huang, et al.. (2024). Enhanced C‐To‐T and A‐To‐G Base Editing in Mitochondrial DNA with Engineered DdCBE and TALED (Adv. Sci. 3/2024). Advanced Science. 11(3). 1 indexed citations
3.
Li, Guoling, Xue Dong, Jiamin Luo, et al.. (2024). Engineering TadA ortholog-derived cytosine base editor without motif preference and adenosine activity limitation. Nature Communications. 15(1). 8090–8090. 6 indexed citations
4.
Yang, Dong, Xiaoqing Wu, Yinan Yao, et al.. (2024). An RNA editing strategy rescues gene duplication in a mouse model of MECP2 duplication syndrome and nonhuman primates. Nature Neuroscience. 28(1). 72–83. 6 indexed citations
5.
Yang, Dong, Yu Zhang, Qingquan Xiao, et al.. (2024). Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model. Nature Communications. 15(1). 5927–5927. 15 indexed citations
6.
Jin, Ming, Zhifang Li, Yang Dong, et al.. (2024). Correction of human nonsense mutation via adenine base editing for Duchenne muscular dystrophy treatment in mouse. Molecular Therapy — Nucleic Acids. 35(2). 102165–102165. 10 indexed citations
7.
Ji, Quanquan, Xinxin Ke, Hufeng Zhou, et al.. (2024). Repurposing Type I-A CRISPR-Cas3 for a robust diagnosis of human papillomavirus (HPV). Communications Biology. 7(1). 858–858. 12 indexed citations
8.
Wei, Yinghui, Ming Jin, Shuhong Huang, et al.. (2023). Enhanced C‐To‐T and A‐To‐G Base Editing in Mitochondrial DNA with Engineered DdCBE and TALED. Advanced Science. 11(3). e2304113–e2304113. 10 indexed citations
9.
Yan, Zixiang, Xiaoqing Wu, Meng Zhang, et al.. (2023). Ptbp1 knockdown failed to induce astrocytes to neurons in vivo. Gene Therapy. 30(12). 801–806. 14 indexed citations
10.
Yan, Zixiang, Yuqin Yao, Luyao Li, et al.. (2023). Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice. Molecular Therapy — Nucleic Acids. 33. 750–761. 14 indexed citations
11.
Zhou, Yingsi & Chunlong Xu. (2023). Miniature genome editors derived from engineering Cas9 ancestor. 1(1). 100008–100008.
12.
Xiao, Qingquan, Zhijiao Xu, Yuanyuan Xue, et al.. (2022). Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor. Science Translational Medicine. 14(654). eabn0449–eabn0449. 66 indexed citations
13.
Li, Guoling, Ming Jin, Zhifang Li, et al.. (2022). Mini-dCas13X–mediated RNA editing restores dystrophin expression in a humanized mouse model of Duchenne muscular dystrophy. Journal of Clinical Investigation. 133(3). 30 indexed citations
14.
Xu, Chunlong, Yingsi Zhou, Qingquan Xiao, et al.. (2021). Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes. Nature Methods. 18(5). 499–506. 232 indexed citations breakdown →
15.
Liu, Zheng‐Li, et al.. (2020). miR-223 induces retinal ganglion cells apoptosis and inflammation via decreasing HSP-70 in vitro and in vivo. Journal of Chemical Neuroanatomy. 104. 101747–101747. 17 indexed citations
16.
Xu, Chunlong, Sen Wu, Lawrence B. Schook, & Kyle M. Schachtschneider. (2019). Translating Human Cancer Sequences Into Personalized Porcine Cancer Models. Frontiers in Oncology. 9. 105–105. 6 indexed citations
17.
Zhang, Meiling, Changyang Zhou, Wei Yu, et al.. (2019). Human cleaving embryos enable robust homozygotic nucleotide substitutions by base editors. Genome biology. 20(1). 101–101. 21 indexed citations
18.
Yang, Dapeng, Sonali Majumdar, Federico Gonzãlez, et al.. (2018). DICER1 Is Essential for Self-Renewal of Human Embryonic Stem Cells. Stem Cell Reports. 11(3). 616–625. 23 indexed citations
19.
Sui, Dandan, Zhaolin Sun, Chunlong Xu, et al.. (2014). Fine-Tuning of iPSC Derivation by an Inducible Reprogramming System at the Protein Level. Stem Cell Reports. 2(5). 721–733. 11 indexed citations
20.
Xu, Chunlong, et al.. (1989). Fluorescence characteristics of photoautotrophic soybean cells. Photosynthesis Research. 21(2). 93–106. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026